Albrechtsen D, Bratlie A, Kiss E, Solheim B G, Thoresen A B, Winther N, Thorsby E
Transplantation. 1979 Oct;28(4):280-4. doi: 10.1097/00007890-197910000-00003.
Matching for HLA haplotypes as well as for HLA-A and B antigens improved graft survival in 112 living related first transplants. In cadaveric first transplants, matching for HLA-A and B antigens had a beneficial effect on the fate of 373 grafts, while matching for HLA-C antigens had no predictive value. One hundred seventeen cadaveric transplants and their recipients were prospectively typed for the HLA-DR antigens. Compatibility for HLA-DR was found to be prognostically beneficial irrespective of matching for HLA-A and B antigens, and with no difference between transfused and nontransfused patients. Matching both for HLA-A , B and D/DR was thus found to influence the outcome of renal transplantation.
在112例亲属活体首次移植中,HLA单倍型以及HLA - A和B抗原配型改善了移植物存活情况。在尸体首次移植中,HLA - A和B抗原配型对373例移植物的转归有有益影响,而HLA - C抗原配型没有预测价值。对117例尸体移植及其受者进行了HLA - DR抗原的前瞻性分型。发现HLA - DR相容性无论对HLA - A和B抗原配型与否均有预后益处,且输血患者与未输血患者之间无差异。因此发现HLA - A、B和D/DR配型均会影响肾移植的结果。